Author
Matthew Royle

Matthew Royle, Ph.D.

Partner

Read More
Author
Matthew Royle

Matthew Royle, Ph.D.

Partner

Read More

17 December 2019 |

Biosimilars – The economics of biosimilars: Market access, pricing and legal considerations

The fourth and final session of our 2019 webinar series focuses on the economic and legal factors affecting biosimilar pricing and uptake.

NERA Economic Consulting experts David Blackburn, Ph.D. and Rasmus Jørgensen, Ph.D. provide their unique insights in the US and European biosimilar markets, including a discussion of key similarities and differences in pricing and market access in the two regions.

Willkie partner Heather M. Schneider and Taylor Wessing partner Matthew Royle discuss key legal aspects of biosimilar regulation that may be affecting pricing and market access.

This session also provides a brief update on key biosimilar decisions, legislation and events from 2019.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Pills
Life sciences & healthcare

Biologics and biosimilars litigation update

25 November 2020
Quick read

by multiple authors

Click here to find out more
centrifuge-machine
Life sciences & healthcare

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

27 July 2020
QUICK READ

by multiple authors

Click here to find out more
woman-with-scientific-model
Life sciences & healthcare

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29 April 2020

by multiple authors

Click here to find out more

Related events

There are no upcoming events